LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2013-06-05 for LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK manufactured by Pluromed Inc..

Event Text Entries

[3629029] Ventricular fibrillation [ventilator fibrillation]. Undissolved legoo remaining in vessel [product solubility abnormal]. Case description: spontaneous report was received on (b)(6) 2013 from a physician regarding a (b)(6) male pt, initials unk. The pt's medical history was not provided. On an unspecified date, the pt received legoo (endovascular occlusion gel) injection, dosage regimen not provided, during off-pump cabg (coronary artery bypass grafting). The lot number for legoo was not provided. It was reported that legoo was used to occlude 3 vessels and was dissolved using cold saline successfully each time. The same day (on an unk date), the pt experienced the life-threatening event of ventricular fibrillation at the end of the off pump cabg (coronary artery bypass grafting) case. It was reported by the physician that there could have been a possibility of an air embolism causing ventricular fibrillation due to some undissolved legoo remaining in the vessel (product dissolution abnormal) which caused an air pocket when it dissolved after the anastomosis was complete. On an unspecified date, the event of ventricular fibrillation resolved. The outcome for the event of "undissolved legoo remaining in the vessel was not provided. Relevant concomitant medications were not provided. The intensity for the event of ventricular fibrillation was severe. The intensity for the event of "undissolved legoo remaining in the vessel" was not provided. The causal relationship between legoo and the events was not provided by the reporting physician.
Patient Sequence No: 1, Text Type: D, B5


[10951623] Mfr's comment: as only limited info has been obtained so far, it is difficult to assess a cause and effect relationship.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3008867907-2013-00004
MDR Report Key3202310
Report Source05,07
Date Received2013-06-05
Date of Report2013-05-30
Date Mfgr Received2013-05-30
Date Added to Maude2013-07-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactBRUNO MENDEZ
Manufacturer Street675 WEST KENDALL STREET
Manufacturer CityCAMBRIDGE MA 02142
Manufacturer CountryUS
Manufacturer Postal02142
Manufacturer Phone6177686173
Manufacturer G1PLUROMED INC.
Manufacturer Street175 NEW BOSTON ST SUITE F
Manufacturer CityWOBURN MA 01801
Manufacturer CountryUS
Manufacturer Postal Code01801
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION
Generic NameENDOVASCULAR OCCLUSION GEL
Product CodeOBC
Date Received2013-06-05
Model NumberUNK
Catalog NumberUNK
Lot NumberUNK
ID NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerPLUROMED INC.
Manufacturer AddressWOBURN MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2013-06-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.